Martin Tami Tillotson

CIK 00015394941 companyROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001539494

Recent Transactions

48 trades

Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-23−1,250→ 3,750 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23+1,250→ 87,418 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23$29.06/sh−485→ 86,933 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-22+750→ 86,414 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-22$27.94/sh−246→ 86,168 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2024-02-22−750→ 1,500 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-01-10$27.91/sh−8,000→ 85,664 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-01-10$9.24/sh+8,000→ 93,664 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-01-10−8,000→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2023-08-30−8,100→ 13,900 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-08-30$23.99/sh+8,100→ 93,349 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-08-30$32.00/sh−8,100→ 85,249 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-08-25$31.59/sh−5,135→ 85,249 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2023-02-23+20,000→ 20,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-23+5,000→ 5,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-22+750→ 90,323 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-22−750→ 2,250 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-22+750→ 90,323 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-22−750→ 2,250 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-22$38.57/sh−289→ 90,034 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-16+1,500→ 88,720 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-02-16−1,500→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-01-12+1,500→ 1,500 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-08-22$7.90/sh+5,000→ 92,220 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-08-22$35.98/sh−5,000→ 87,220 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-08-22−5,000→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-08-04$7.90/sh+5,000→ 92,220 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-08-04$32.98/sh−5,000→ 87,220 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-08-04−5,000→ 5,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-02-22+18,000→ 18,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2022-02-22+3,000→ 3,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2022-02-22+3,000→ 3,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-02-22+18,000→ 18,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2021-04-14−3,125→ 6,250 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2021-04-14$31.98/sh−3,125→ 86,326 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2021-04-14$12.98/sh+3,125→ 89,451 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2021-04-13$29.98/sh−3,125→ 86,326 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2021-04-13−3,125→ 9,375 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2021-04-13$12.98/sh+3,125→ 89,451 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2021-02-19+17,000→ 17,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2020-02-21+22,000→ 22,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2012-12-12$1.60/sh+37,500→ 40,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2012-12-12$3.36/sh+1,250→ 41,250 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (right to buy)
2012-12-12−1,250→ 1,250 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2012-12-12$2.56/sh+9,375→ 50,625 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (right to buy)
2012-12-12−37,500→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (right to buy)
2012-12-12−9,375→ 28,125 total
Purchase
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2012-05-04$5.00/sh+2,500→ 2,500 total

Companies

SUPERNUS PHARMACEUTICALS, INC.
VP of Regulatory Affairs
$SUPN

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE

ROCKVILLE, MD, 20850

View on SEC.gov